Search clinical trials for: Unresectable melanoma

Total 5808 results

Zhejiang Cancer Hospital

Unknown

Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer

Drug Safety | Surgically-Created Resection Cavity

China
National Cancer Institute (NCI)

Completed

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Melanoma | Neoplasm Metastasis

United States
University of Tennessee Cancer Institute
Wyeth is now a wholly owned subsidiary of Pfizer

Unknown

Temsirolimus as Second-line Therapy in HCC

Unresectable or Metastatic Hepatocellular Carcinoma

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma

Intraocular Melanoma | Melanoma (Skin)

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Melanoma Biomarker Study

Metastatic Melanoma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Withdrawn

Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Infinity Pharmaceuticals, Inc.
AstraZeneca; MedImmune LLC

Terminated

Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib

Gastrointestinal Stromal Tumors
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer

Breast Cancer | Metastatic Cancer

United States
Infinity Pharmaceuticals, Inc.

Terminated

A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
Immodulon Therapeutics Ltd
Theradex; HCA International Limited

Completed

A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients

Melanoma

United Kingdom
Piramal Enterprises Limited

Completed

Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression (ENVER)

Melanoma

Australia, India, New Zealand
Massachusetts General Hospital
National Cancer Institute (NCI)

Terminated

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Depression | Fatigue | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

United States
Prof. Serge Leyvraz

Completed

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

Melanoma (Skin)

Switzerland
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
NYU Langone Health
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer

Ovarian Cancer

United States
George Albert Fisher

Completed

Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer

Pancreatic Cancer

United States
Ruhr University of Bochum

Completed

Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma

Cutaneous Malignant Melanoma

Germany
National Cancer Institute (NCI)

Completed

Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer

Metastatic Melanoma | Metastatic Kidney Cancer

United States
Taiho Pharmaceutical Co., Ltd.

Completed

Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer

Colorectal Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)

Colorectal Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

Colorectal, Cancer

Japan
Taiho Pharmaceutical Co., Ltd.
Daiichi Sankyo Co., Ltd.

Completed

Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

Colorectal Cancer

Japan
Mt. Sinai Medical Center, Miami
Amgen

Completed

Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Unresectable Locally Advanced NSCLC

United States
National Cancer Institute (NCI)

Terminated

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Melanoma | Malignant Melanoma | Melanoma, Experimental

United States
Amr Hafez
Ain Shams University

Completed

Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4

Hepatitis C
National Cancer Institute (NCI)

Completed

Peptide Vaccination for Patients at High Risk for Recurrent Melanoma

Melanoma

United States
M.D. Anderson Cancer Center
National Comprehensive Cancer Network

Completed

CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer

United States
Indiana University

Completed

Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study

Pancreatic Cancer

United States
National Cancer Institute (NCI)

Completed

Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma

High-Risk Melanoma

United States
National Cancer Institute (NCI)

Completed

Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma

Metastatic Melanoma

United States
Cytheris SA
Cytheris, Inc.

Terminated

Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer

Kidney Cancer | Melanoma (Skin)

United States
Sun Yat-sen University
Zhejiang Cancer Hospital; Fifth Affiliated Hospital, Sun Yat-Sen University; Guangzhou... and other collaborators

Unknown

Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer (DP-EN-RT)

Non-small Cell Lung Cancer

China
Ruhr University of Bochum

Completed

miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi

Cutaneous Melanoma | Nevi

Germany
Ruhr University of Bochum

Completed

Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi

Malignant Melanoma | Naevi

Germany
Cliniques universitaires Saint-Luc- Université...
Institut Pasteur

Unknown

Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients (THERAVAC)

Melanoma

Belgium
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer

Liver Cancer
Lucid, Inc.
Memorial Sloan Kettering Cancer Center; University of Rochester; Loma Linda University and other collaborators

Completed

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Melanoma | Skin Cancer | Lentigo Maligna

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma

Melanoma | Solid Tumor | Brain and Central Nervous System Tumors

United States
Saint John's Cancer Institute
Melanoma Research Alliance

Terminated

Stage IV Surgery Versus Best Medical Therapy (STG4SURG)

Stage IV Resectable Melanoma

United States, Australia, Israel, Italy, Netherlands
Centre Georges Francois Leclerc
Pfizer; Hoffmann-La Roche; National Cancer Institute, France; UNICANCER; Association...

Completed

Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma (TemAvIr)

Naive Unresectable Glioblastoma

France
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

Melanoma (Skin)

United States
Allergan

Completed

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Glabellar Frown Lines

United States
European Organisation for Research and Treatment...
Institute of Cancer Research, United Kingdom; Arbeitsgruppe Lebermetastasen...

Terminated

Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

Netherlands, United Kingdom, Belgium, France, Germany, Sweden, Hungary, Austria, Egypt, Italy
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured

Melanoma (Skin)

United States
European Organisation for Research and Treatment...

Terminated

Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain

Metastatic Cancer | Melanoma (Skin)

France, Norway, Belgium, Netherlands, United Kingdom, Austria, Czech Republic, Germany, Italy, Portugal, Switzerland
European Organisation for Research and Treatment...

Terminated

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Intraocular Melanoma

Belgium, Denmark
Daiichi Sankyo, Inc.

Completed

CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Germany
Agenus Inc.

Completed

Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma

Malignant Melanoma

United States, Australia, Poland, Ukraine, United Kingdom, Russian Federation, Hungary, Italy, Sweden
Medical University of Vienna

Unknown

In-vivo Optical Coherence Tomography Imaging in Dermatooncology

Non-melanocytic Skin Tumors | Melanocytic Skin Tumors

Austria

Search clinical trials for: Unresectable melanoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations